Approvals/TGA/XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial

Approved

STANDARD

XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial

Grifols Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a586d40f18af8d54
Product Name: XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial
Artg Id: 380404
Artg Name: XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial
Sponsor: Grifols Australia Pty Ltd
Company Detail Path: /organization/grifols-australia-pty-ltd
Artg Date: 2022-06-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4c5fd003b66cc9305365b02ec8f2bf5c.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/3789e000d2ecc386ab2102eb7ee52932.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

a586d40f18af8d54

Type

Standard